Strikingly, the result showed that PXR reduced the MDM2 half-life in colon cancer cells (Figure 5E), and PXR increased endogenous ubiquitination of MDM2 (Figure 5F). The gene discussed is NR1I2; the disease is malignant colon neoplasm.